BR0102776A - Mutante ibdv, vacina para uso na proteção de aves domésticas contra doença causada por infecção por ibdv, uso de um mutante ibdv, e, método para a proteção de aves domésticas contra doença causada por infecção por ibdv - Google Patents

Mutante ibdv, vacina para uso na proteção de aves domésticas contra doença causada por infecção por ibdv, uso de um mutante ibdv, e, método para a proteção de aves domésticas contra doença causada por infecção por ibdv

Info

Publication number
BR0102776A
BR0102776A BR0102776-0A BR0102776A BR0102776A BR 0102776 A BR0102776 A BR 0102776A BR 0102776 A BR0102776 A BR 0102776A BR 0102776 A BR0102776 A BR 0102776A
Authority
BR
Brazil
Prior art keywords
ibdv
disease caused
infection
mutant
vaccine
Prior art date
Application number
BR0102776-0A
Other languages
English (en)
Inventor
Egbert E Mundt
Adriaan Antonius Wilhelmu Loon
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0102776A publication Critical patent/BR0102776A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"MUTANTE IBDV, VACINA PARA USO NA PROTEçãO DE AVES DOMéSTICAS CONTRA DOENçA CAUSADA POR INFECçãO POR IBDV, USO DE UM MUTANTE IBDV, E, MéTODO PARA A PROTEçãO DE AVES DOMéSTICAS CONTRA DOENçA CAUSADA POR INFECçãO POR IBDV". A presente invenção provê uma vacina IBDV de largo espectro, que é capaz de induzir uma imune resposta protetora contra cepas IBDV clássicas e variante E. Além disso, a vacina pode é administrada a aves domésticas por rotas de aplicação em massa.
BR0102776-0A 2000-07-07 2001-07-06 Mutante ibdv, vacina para uso na proteção de aves domésticas contra doença causada por infecção por ibdv, uso de um mutante ibdv, e, método para a proteção de aves domésticas contra doença causada por infecção por ibdv BR0102776A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202430 2000-07-07
EP01201064 2001-03-22

Publications (1)

Publication Number Publication Date
BR0102776A true BR0102776A (pt) 2002-07-23

Family

ID=26072471

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0102776-0A BR0102776A (pt) 2000-07-07 2001-07-06 Mutante ibdv, vacina para uso na proteção de aves domésticas contra doença causada por infecção por ibdv, uso de um mutante ibdv, e, método para a proteção de aves domésticas contra doença causada por infecção por ibdv

Country Status (13)

Country Link
US (1) US6485940B2 (pt)
JP (1) JP2002095485A (pt)
KR (1) KR100759769B1 (pt)
CN (1) CN1257973C (pt)
AT (1) ATE330969T1 (pt)
AU (1) AU780878B2 (pt)
BR (1) BR0102776A (pt)
CA (1) CA2351010C (pt)
DE (1) DE60120840T2 (pt)
HU (1) HU225488B1 (pt)
MX (1) MXPA01006919A (pt)
NZ (1) NZ512800A (pt)
PL (1) PL199159B1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE484579T1 (de) * 2003-03-24 2010-10-15 Intervet Int Bv Infektiöse bursitis-virus mutanten und impfstoffe
US7491399B2 (en) * 2005-06-23 2009-02-17 University Of Maryland Biotechnology Institute In Ovo vaccine against infectious bursal disease
CN100384990C (zh) * 2005-11-14 2008-04-30 浙江大学 传染性法氏囊病病毒无毒力毒株构建方法
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7955591A (en) 1990-05-04 1991-11-27 University Of Maryland At College Park, The Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
US5788970A (en) 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
CA2238659C (en) * 1997-05-26 2010-12-14 Akzo Nobel N.V. Recombinant birnavirus vaccine
WO2000012677A2 (en) 1998-09-01 2000-03-09 The University Of Hong Kong Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines

Also Published As

Publication number Publication date
CA2351010C (en) 2010-12-14
US20020064532A1 (en) 2002-05-30
JP2002095485A (ja) 2002-04-02
HU0102823D0 (en) 2001-09-28
NZ512800A (en) 2002-03-01
PL348550A1 (en) 2002-01-14
CN1366041A (zh) 2002-08-28
HU225488B1 (en) 2006-12-28
KR100759769B1 (ko) 2007-10-04
AU5419601A (en) 2002-01-10
HUP0102823A3 (en) 2005-06-28
AU780878B2 (en) 2005-04-21
CA2351010A1 (en) 2002-01-07
DE60120840D1 (de) 2006-08-03
DE60120840T2 (de) 2006-11-16
KR20020013387A (ko) 2002-02-20
ATE330969T1 (de) 2006-07-15
PL199159B1 (pl) 2008-08-29
HUP0102823A2 (hu) 2002-04-29
US6485940B2 (en) 2002-11-26
MXPA01006919A (es) 2003-09-25
CN1257973C (zh) 2006-05-31

Similar Documents

Publication Publication Date Title
RS51699B (sr) Beta-amiloid-analog-t-ćelijski-epitop vakcina
FI970799A (fi) Mutanttientoroksiini, joka on tehokas ei-toksinen oraalinen adjuvantti
AR087241A2 (es) Derivados de 6-oh-4h-benzo[1,4]oxazin-3-ona para el tratamiento de la enfermedad pulmonar obstructiva cronica
CU23260B7 (es) PREPARADO FARMACéUTICO DE MOXIFLOXACINA
BRPI0407845A (pt) formulação intranasal de rotigotina
BRPI9609414B8 (pt) combinação de vacina e kit para produzir a mesma.
ES2173300T3 (es) Vacunas de virus vivos prrs de baja patogenicidad y metodos para su preparacion.
BRPI0407950A (pt) processo para a preparação de uma composição de higiene pessoal
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
BR0109322A (pt) Materiais e métodos de vacina de salmonella
BR9914940A (pt) Método para aperfeiçoar a farmacocinética de tipranavir
BR9809508A (pt) Agente terapêutico para disfunção de ereção
HUP0301634A2 (hu) Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera
BR0102776A (pt) Mutante ibdv, vacina para uso na proteção de aves domésticas contra doença causada por infecção por ibdv, uso de um mutante ibdv, e, método para a proteção de aves domésticas contra doença causada por infecção por ibdv
BR9811319A (pt) Método para proteger um animal contra umadoença crÈnica
ATE392214T1 (de) Impfstoff gegen geschlechtlich übertragene krankheiten
TR201820975A2 (tr) İbuprofen, Psödoefedrin ve Erdostein İçeren Uzatılmış Salım Sağlayan Farmasötik Kompozisyon
HUP0401077A2 (hu) Mycoplasma bovis fertőzési modell, valamint eljárások M. bovis bejuttatására és tüdőgyulladásos tüdőléziók indukálására
BRPI0410355A (pt) composição de vacina aviária para a proteção de aves contra doença e infecção causadas por e. coli e samonella
BR0208980A (pt) Vacinas incluindo ifn do tipo i como um adjuvante e processos relacionados a esses
BR9812131A (pt) Composições contendo bergamotina para aumentar a biodisponibilidade oral de agentes farmacêuticos
NO20024574D0 (no) Anvendelse av CDP-kolin for behandling av alkoholabstinens
BR0314349A (pt) Astrovìrus tipo 2 de galinha (castv-2), cultura de células, vacina para uso na proteção de aves domésticas contra doenças causadas pela infecção por astrovìrus aviário, e, métodos para a preparação de material antìgeno de castv-2, para a preparação de uma vacina e para a proteção de aves domésticas, em particular galinhas, contra doença causada pela infecção por astrovìrus aviário
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ES2192608T3 (es) Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2223 DE 13/08/2013.